Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Inventory (2018 - 2025)

Marimed (MRMD) has disclosed Inventory for 8 consecutive years, with $36.6 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 9.3% to $36.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.6 million through Dec 2025, up 9.3% year-over-year, with the annual reading at $36.6 million for FY2025, 9.3% up from the prior year.
  • Inventory for Q4 2025 was $36.6 million at Marimed, down from $40.0 million in the prior quarter.
  • The five-year high for Inventory was $40.0 million in Q3 2025, with the low at $7.5 million in Q1 2021.
  • Average Inventory over 5 years is $24.1 million, with a median of $24.5 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 174.5% in 2021, then increased 9.3% in 2025.
  • Over 5 years, Inventory stood at $9.8 million in 2021, then skyrocketed by 99.4% to $19.5 million in 2022, then grew by 29.93% to $25.3 million in 2023, then skyrocketed by 32.33% to $33.5 million in 2024, then rose by 9.3% to $36.6 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $36.6 million, $40.0 million, and $38.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.